MedPath

To use biochemical properties of vaginal discharge for possible diagnosis of bacterial vaginosis and predict treatment outcome.

Not Applicable
Conditions
Health Condition 1: N898- Other specified noninflammatory disorders of vagina
Registration Number
CTRI/2018/12/016508
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients who are BV positive using Amsel criteria

2. BV positive women in the reproductive age group (18-45 years)

3. Presence of abnormal vaginal discharge

Exclusion Criteria

Presence of co-existing STIs contributing to discharge

2. Patients who are HIV positive

3. Iatrogenic or systemic illness or metabolic disorders.

4. Presence of associated co-morbidities

5. Patients who have received oral drugs within the last 4 weeks

6. Patients who have received topical or intravaginal treatment within the last 4 weeks

7. Pregnant and lactating women

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To analyze the microbiota compositiion and metabolic profiles of women with bacterial vaginosis and compare them with health controls.Timepoint: 0, 4 weeks, 1 year/relapse whichever earlier
Secondary Outcome Measures
NameTimeMethod
To explore diagnostic and/or predictive potential of metabolomics by comparing with existing diagnostic modalities.Timepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath